Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06136260 · ClinicalTrials.gov registry record · NA

The Grief Navigation Trial: A Comparison of Two Interventions to Support Parents After Their Child's Unexpected or Traumatic Death

A NA study of Bereavement, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

Recruiting
Registry status
NA
Development phase
2,000
Enrollment target
7
Study locations

NCT06136260: Recruiting NA study of Bereavement, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

NCT06136260 is a NA study of Bereavement that is actively recruiting participants, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 2,000 participants, above the 155-participant average among 7 other Bereavement trials with a reported enrollment target (1190% higher). The trial reports 7 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06136260, a NA study of Bereavement, is actively recruiting participants, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.

RECRUITING
Registry status
NA
Development phase
2,000 participants
Enrollment target
7
Study locations

Study Summary

Parents of children who die traumatically or unexpectedly from things like suicide or an overdose suffer from mental and physical health problems and can experience massive disruptions in their family life. For about half of these parents, the first, and sometimes only, interactions they have with the healthcare system when their child dies are with a medical examiner or coroner (hereafter 'ME'). But MEs have little to no training in helping grieving families, and there are no standards guiding medical examiners or coroners on how or even if they should help grieving families. This gap leaves parents to find the help they need on their own. This research will test two different strategies for addressing this gap in the healthcare system.

Primary Outcome

Domain-specific item assessing self-efficacy related to support after a child's death, based on Bandura's Self-Efficacy Scale, "How confident are you in your ability to find resources to support you after your child's death?" Responses are on a 5-point Likert scale ranging from "not at all confident" to "completely confident."

Conditions Studied

Interventions

  • OTHER CommunityRx-Bereavement
  • OTHER General Bereavement Support Information

Study Locations (7)

Illinois

  • Cook County Medical Examiner's Office - Chicago
  • Will County Coroner's Office - Joliet
  • Peoria County Coroner's Office - Peoria
  • Kane County Coroner's Office - Saint Charles
  • Lake County Coroner's Office - Waukegan
  • DuPage County Coroner's Office - Wheaton
  • McHenry County Coroner's Office - Woodstock

Trial Details

FieldValue
Enrollment Target 2,000 participants
Start Date 2024-03-04
Est. Completion 2028-02
Phase NA

What NCT06136260 shows while recruiting

NCT06136260 is an interventional study that assigns participants to a tested intervention. Its 2,000 participants enrollment target places it among the larger protocols in the corpus, above the 155-participant average among 7 other Bereavement trials with a reported enrollment target (1190% higher).

The record links to 1 condition, with Bereavement appearing as the primary indexed condition, and to 2 interventions - of which CommunityRx-Bereavement is the first listed.

NCT06136260 lists 7 locations in 1 state (Illinois).

Frequently Asked Questions

What is clinical trial NCT06136260 about?

NCT06136260 is a clinical study titled "The Grief Navigation Trial: A Comparison of Two Interventions to Support Parents After Their Child's Unexpected or Traumatic Death". Parents of children who die traumatically or unexpectedly from things like suicide or an overdose suffer from mental and physical health problems and can experience massive disruptions in their family life. For about half of these parents, the first, and sometimes only, interactions they have with t...

What is the current status of trial NCT06136260?

This trial is currently recruiting. It is a NA study. The enrollment target is 2,000 participants. The study started on 2024-03-04. Estimated completion is 2028-02.

What conditions does trial NCT06136260 study?

This clinical trial studies the following conditions: Bereavement.

What interventions are being tested in trial NCT06136260?

The interventions under investigation include: CommunityRx-Bereavement (OTHER), General Bereavement Support Information (OTHER).

Who is sponsoring clinical trial NCT06136260?

This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06136260 being conducted?

This trial has 7 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bereavement

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00001465 · 2,000 participants

    Study of the Disease Process of Lymphangioleiomyomatosis

  • NCT00001595 · 2,000 participants

    An Investigation of Pituitary Tumors and Related Hypothalmic Disorders

  • NCT00138931 · 2,000 participants

    Genetics of Cardiovascular and Neuromuscular Disease

  • NCT00288119 · 2,000 participants

    Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06136260, the US trial registry maintained by the National Library of Medicine. NCT06136260 (large enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.